Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-24 4:12 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Aug-24 | Option Exercise | 20,725 | $89.09 | $1,846,430.00 | 141% 14.72K to 35.44K | |
| 14-Aug-24 4:12 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Aug-24 | Planned Option Sale | 20,725 | $270.99 | $5,616,230.00 | (58%) 35.44K to 14.72K | |
| 14-Aug-24 4:12 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Aug-24 | Sale (Planned) | 1,300 | $270.99 | $352,285.00 | (9%) 14.72K to 13.42K | |
| 26-Jun-24 4:26 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jun-24 | Sale | 1,198 | $230.99 | $276,731.00 | (8%) 15.92K to 14.72K | |
| 26-Jun-24 4:26 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 24-Jun-24 | Grant | 2,498 | -- | -- | 19% 13.42K to 15.92K |